AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND

Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease.

HC

فريق هلا كير الطبي

محتوى طبي موثوق من مصادر عالمية معتمدة، تمت مراجعته من قبل أطباء متخصصين لضمان دقة المعلومات

Leave a Reply

Your email address will not be published. Required fields are marked *